Ann: AGM Presentation, page-21

singu,
//vintage is correct. 17% is the mean reduction in proteinuria with the dmx2000. I was looking for this value but couldn't find it written anywhere until this presentation.
//whenever a mean number like that is presented, here's a tip, always ask for the p value (level of statistical significance) and confidence interval. it tells you a lot.
// don't compare with travere phase 3, and go it's 17% v 18% because travere study iresult is much more precise, you're comparing a phase 2 dmx study of what, 7 patients, with 50 times that in traverse sparsentan study.
// another tip when looking at data, always check if percentages are being used to improve presentation of data because a trial is small. 29% and 86% look really good and make you go wow until you realise that meant 2 out of 7 and 6 out of 7.
it's out of the Pharma marketing playbook, you see it all the time.